Anondita Medicare MD Attends UN Human Rights Council Session in Geneva
Anupam Ghosh, Managing Director of Anondita Medicare Limited, represented India on a global platform by attending the 62nd Session of the United Nations Human Rights Council (HRC62) held at Palais des Nations in Geneva, Switzerland.Mr. Ghosh’s participation highlighted the growing presence of Indian entrepreneurs in international forums. The session gathered representatives, organizations, and experts from various countries to share their views on diverse social and developmental matters.
Delivering a speech during the event, Mr. Anupam Ghosh stated that he found it an honor to speak at the United Nations Office in Geneva. He emphasized that such forums are crucial for encouraging dialogue, facilitating the exchange of ideas, and working collaboratively toward addressing global community issues. Ghosh further stated that Anondita Medicare believes responsible businesses play a vital role in improving accessibility, creating awareness, and contributing to sustainable progress.
The event underscored Anondita Medicare’s commitment to operating as a responsible organization driven by innovation and adherence to global standards.
Anondita Medicare Limited operates advanced manufacturing facilities and manufactures male and female condoms under its flagship 'COBRA' brand. The company is focused on strengthening both its domestic and international presence through product diversification, quality focus, and expansion. Supported by operational efficiency and increasing demand, the company is targeting ₹1000 crore in revenue within the next two years.
ANONDITA Stock Price Movement
Today, shares of Anondita Medicare Limited shed value, closing at ₹1172.30 after a 3.53% dip. The stock traded within an intraday range of ₹1130 to ₹1240, recording a volume of 46,200 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.